One of the world’s largest biopharmaceutical manufacturers, AbbVie Inc., headquartered in Illinois, is coming to North Carolina, announced Gov. Josh Stein on April 22, and will invest $1.4 billion to build a 185-acre manufacturing campus in Durham, promising to create 734 jobs.
“We welcome AbbVie’s major investment to North Carolina,” said Stein, in a press release. “When you combine our world-renowned research and innovation with a strong, thriving life sciences hub, North Carolina quickly becomes the premier location for biopharmaceutical companies to do business.”
As part of a $100 billion US commitment to research and development (R&D) capital investments and manufacturing over the next decade, the Durham Campus will be the company’s first investment in the state of North Carolina. The facility will support AbbVie’s manufacturing across therapeutic areas, including immunology, neuroscience, and oncology, by integrating laboratory innovations and enhanced manufacturing with artificial intelligence. The company’s portfolio also includes products and services from Allergan Aesthetics…